Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Celltrion, Inc.

Capitalization 44,981B 29.99B 26.21B 23.68B 22.66B 41.21B 2,774B 42.83B 283B 112B 1,325B 113B 110B 4,786B P/E ratio 2025 *
54.3x
P/E ratio 2026 * 34.8x
Enterprise value 46.21B 30.81M 26.93M 24.33M 23.28M 42.34M 2.85B 44.01M 291M 115M 1.36B 116M 113M 4.92B EV / Sales 2025
9.51x
EV / Sales 2026 * 8.82x
Free-Float
70.87%
Yield 2025 *
0.35%
Yield 2026 * 0.35%
1 day-0.24%
1 week-3.29%
Current month-13.84%
1 month-13.66%
3 months+10.01%
6 months+19.69%
Current year+13.54%
1 week 199,100
Extreme 199100
214,000
1 month 195,900
Extreme 195900
251,000
Current year 188,600
Extreme 188600
251,000
1 year 144,615.38
Extreme 144615.3846
251,000
3 years 119,963.37
Extreme 119963.37
251,000
5 years 119,963.37
Extreme 119963.37
288,761.95
10 years 65,004.08
Extreme 65004.0844
341,497.26
Manager TitleAgeSince
Chief Executive Officer 65 20/03/2015
Chief Executive Officer 42 26/03/2021
Chief Executive Officer 60 20/03/2015
Director TitleAgeSince
Chairman 68 -
Director/Board Member 60 01/04/2005
Director/Board Member 66 -
Change 5d. change 1-year change 3-years change Capi.($)
-0.24%-3.29%+14.84%+48.71% 29.99B
-0.72%-4.60%-12.29%-8.00% 42.78B
-0.44%-5.67%+9.59%+22.80% 31.5B
+1.10%-5.60%-11.05%-17.93% 27.65B
-0.22%-3.60%+142.48%+304.69% 18.8B
-1.32%-6.10%+47.72%+106.64% 13.87B
+1.48%-4.29%+38.61%+148.23% 12.78B
-0.29%-4.80%+24.93%+0.10% 12.39B
-1.59%-3.85%+115.99%+110.87% 11.76B
-3.21%-0.51%+6,894.88%+3,230.94% 11.49B
Average -0.54%-3.83%+726.57%+394.71% 21.3B
Weighted average by Cap. -0.39%-3.88%+397.29%+229.40%

Financials

2025 2026 *
Net sales 4,150B 2.77B 2.42B 2.18B 2.09B 3.8B 256B 3.95B 26.1B 10.34B 122B 10.38B 10.16B 442B 5,210B 3.47B 3.04B 2.74B 2.62B 4.77B 321B 4.96B 32.77B 12.99B 153B 13.04B 12.76B 554B
Net income 868B 579M 506M 457M 437M 796M 53.56B 827M 5.46B 2.16B 25.59B 2.17B 2.13B 92.42B 1,350B 900M 787M 711M 680M 1.24B 83.28B 1.29B 8.49B 3.37B 39.79B 3.38B 3.31B 144B
Net Debt 1,232B 822M 718M 649M 621M 1.13B 75.99B 1.17B 7.75B 3.07B 36.31B 3.08B 3.02B 131B 992B 661M 578M 522M 500M 909M 61.16B 944M 6.24B 2.47B 29.22B 2.48B 2.43B 106B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
13/03/26 205,500.00 -0.24% 516,104
12/03/26 206,000.00 -1.44% 501,196
11/03/26 209,000.00 +1.46% 430,951
10/03/26 206,000.00 +0.98% 489,112
09/03/26 204,000.00 -4.00% 701,450
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
205,500.00KRW
Average target price
253,958.33KRW
Spread / Average Target
+23.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW